NIH Opens Website for Human Embryonic Stem Cell Lines for Approval and Announces Members of Working Group
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., announces that NIH is now accepting requests for human embryonic stem cell (hESC) lines to be approved for use in NIH-funded research.
The NIH Director is also pleased to announce the members of a new working group of the Advisory Committee to the Director (ACD): the Working Group for Human Embryonic Stem Cell Eligibility Review.
NIH is accepting requests for hESCs to be approved for use in NIH-funded research. Information may be submitted through NIH Form 2890, which is available at http://stemcells.nih.gov/.
In announcing the members of the Working Group, Dr. Collins said, "I appreciate the willingness of these individuals to assist NIH in supporting responsible, scientifically worthy human stem cell research, as encouraged by the President's Executive Order. Their expertise and sound judgment will help NIH move forward in this important effort."
Jeffrey R. Botkin, M.D., M.P.H., will serve as the working group's chairman. Dr. Botkin is a professor of pediatrics, Department of Pediatrics, and adjunct professor of medicine, Department of Internal Medicine-Division of Medical Ethics, at University of Utah's School of Medicine. He is also the associate vice president for research integrity at the University of Utah. Dr. Botkin has recently served on the Secretary's Advisory Committee on Human Research Protection.
The other members of the Working Group are:
-- Dena S. Davis, J.D., Ph.D., professor of law, Cleveland-Marshall College of Law, Cleveland State University, Ohio
-- Pamela B. Davis, M.D., Ph.D., dean of the School of Medicine, Case Western Reserve University, Ohio
-- David A. Grainger, M.D., M.P.H., director, Center for Reproductive Medicine; associate dean for research; professor, Department of Obstetrics and Gynecology; director, director, Division of Reproductive Endocrinology; University of Kansas School of Medicine-Wichita.
-- Richard P. Lifton, M.D., Ph.D., chair, Department of Genetics; professor of genetics, medicine and molecular biophysics and biochemistry; investigator, Howard Hughes Medical Institute, Yale School of Medicine, Conn.
-- Bernard Lo, M.D., professor of medicine; director, Program in Medical Ethics; Department of Medicine, University of California, San Francisco.
-- Terry Magnuson, Ph.D., professor and chair of the Department of Genetics of the School of Medicine, University of North Carolina at Chapel Hill.
-- Jeffrey C. Murray, M.D., professor of neonatology and genetics; professor of biological sciences, dentistry, and epidemiology in the College of Public Health; Department of Pediatrics, University of Iowa Children's Hospital;
-- Carlos Pavão, M.P.A., training and technical specialist, Education Development Center. Inc., Atlanta, Ga.; member, NIH Director's Council of Public Representatives.
The NIH Director is also pleased to announce the members of a new working group of the Advisory Committee to the Director (ACD): the Working Group for Human Embryonic Stem Cell Eligibility Review.
NIH is accepting requests for hESCs to be approved for use in NIH-funded research. Information may be submitted through NIH Form 2890, which is available at http://stemcells.nih.gov/.
In announcing the members of the Working Group, Dr. Collins said, "I appreciate the willingness of these individuals to assist NIH in supporting responsible, scientifically worthy human stem cell research, as encouraged by the President's Executive Order. Their expertise and sound judgment will help NIH move forward in this important effort."
Jeffrey R. Botkin, M.D., M.P.H., will serve as the working group's chairman. Dr. Botkin is a professor of pediatrics, Department of Pediatrics, and adjunct professor of medicine, Department of Internal Medicine-Division of Medical Ethics, at University of Utah's School of Medicine. He is also the associate vice president for research integrity at the University of Utah. Dr. Botkin has recently served on the Secretary's Advisory Committee on Human Research Protection.
The other members of the Working Group are:
-- Dena S. Davis, J.D., Ph.D., professor of law, Cleveland-Marshall College of Law, Cleveland State University, Ohio
-- Pamela B. Davis, M.D., Ph.D., dean of the School of Medicine, Case Western Reserve University, Ohio
-- David A. Grainger, M.D., M.P.H., director, Center for Reproductive Medicine; associate dean for research; professor, Department of Obstetrics and Gynecology; director, director, Division of Reproductive Endocrinology; University of Kansas School of Medicine-Wichita.
-- Richard P. Lifton, M.D., Ph.D., chair, Department of Genetics; professor of genetics, medicine and molecular biophysics and biochemistry; investigator, Howard Hughes Medical Institute, Yale School of Medicine, Conn.
-- Bernard Lo, M.D., professor of medicine; director, Program in Medical Ethics; Department of Medicine, University of California, San Francisco.
-- Terry Magnuson, Ph.D., professor and chair of the Department of Genetics of the School of Medicine, University of North Carolina at Chapel Hill.
-- Jeffrey C. Murray, M.D., professor of neonatology and genetics; professor of biological sciences, dentistry, and epidemiology in the College of Public Health; Department of Pediatrics, University of Iowa Children's Hospital;
-- Carlos Pavão, M.P.A., training and technical specialist, Education Development Center. Inc., Atlanta, Ga.; member, NIH Director's Council of Public Representatives.
